Regulatory Evolution: Navigating the FDA’s 2025 Modernization
In 2025, the FDA has fully implemented its multi-year modernization initiative, introducing new standards for data integrity and clinical trial diversity. These regulations require sponsors to provide "Diversity Action Plans" before a trial begins, ensuring that the participants reflect the diverse demographic makeup of the US population. Additionally, there is a heightened focus on the use of...
0 Commenti 0 condivisioni 213 Views 0 Anteprima